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Introduction
Bovine respiratory disease complex (BRDC) is the most sig-
nificant disease in beef cattle production, which in 2011 was 
worth an estimated retail value of $79 billion in the United 
States. BRDC is estimated to cost producers more than $13 
per animal, making the economic impact to cattle production 
tremendous.24 The total overall cost to the United States is 
estimated to be >$1 billion as a result of production losses, 
death, labor, and drug costs.7,9 Although effective antimicro-
bials and vaccines for BRDC have been licensed and are 
available, the incidence of BRDC in feedlot cattle remains 
high, with 62–72% of animals having lung lesions at slaugh-
ter indicative of prior BRDC, and with 61–68% of these 
never having been treated.23,25 This tremendous cost and high 
incidence of undiagnosed disease underscores the need for 
new rapid and accurate tools to mitigate the impact of BRDC 
on beef cattle production and enable targeted prevention and 
treatment strategies.
Multiple pathogens, including both viruses and bacteria, 
contribute to BRDC. The complex is frequently initiated by 
infection with a virus that is subsequently exacerbated by 
stress from transport and commingling. Such stress disrupts 
local defenses and causes immune suppression, which enables 
bacteria that are normal nasopharyngeal commensals to colo-
nize deeper respiratory tissues, replicate, and secrete toxins in 
lower airways causing tissue destruction, inflammation, and 
pneumonia.18 Bacterial pathogens that are isolated frequently 
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Abstract. Bovine respiratory disease complex (BRDC) is one of the most significant diseases of cattle. Bacterial pathogens 
involved in BRDC include Mannheimia haemolytica, Mycoplasma bovis, Histophilus somni, and Pasteurella multocida. We 
developed and evaluated a multiplexed real-time hydrolysis probe (rtPCR) assay using block-based Peltier and rotary-based 
thermocycling on lung tissue, nasal swabs, and deep nasopharyngeal swabs. The rtPCR results were compared to culture 
or a gel-based M. bovis PCR using statistical analysis to determine optimum quantification cycle (Cq) cutoffs to maximize 
agreement. The limits of detection were 1.2–12 CFU/reaction for each pathogen. M. haemolytica was the most prevalent 
organism detected by rtPCR, and was most frequently found with P. multocida. The rtPCR assay enabled enhanced levels of 
detection over culture for all pathogens on both thermocycling platforms. The rotary-based thermocycler had significantly 
lower Cq cutoffs (35.2 vs. 39.7), which maximized agreement with gold standard culture or gel-based PCR results following 
receiver operating characteristic analysis to maximize sensitivity (Se) and specificity (Sp). However, overall assay Se and Sp 
were similar on both platforms (80.5% Se, 88.8% Sp vs. 80.1% Se, 88.3% Sp). Implementation of these tests could enhance 
the detection of these pathogens, and with high-throughput workflows could reduce assay time and provide more rapid results. 
The assays may be especially valuable in identifying coinfections, given that many more antemortem samples tested in our 
study were positive for 2 or more pathogens by rtPCR (n = 125) than were detected using culture alone (n = 25).
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in association with BRDC include: Mannheimia haemolytica, 
Pasteurella multocida, Histophilus somni, and Mycoplasma 
bovis. A 2014 study investigating a large number of BRDC 
mortalities in North American bovine feedlots showed M. 
haemolytica to be the most frequently isolated (91%), fol-
lowed by M. bovis (63%), H. somni (57%), and P. multocida 
(13%).12 This supports other studies showing frequent isola-
tion or detection of these agents in North American feed-
lots.2,12 Identification of the pathogens responsible for BRDC 
is critical to development of effective prevention and treat-
ment strategies, because some therapies, such as beta-lactam 
antimicrobials, are ineffective against M. bovis, and several of 
the pathogens have shown in vitro resistance to available anti-
microbial therapies.16,21
Classically, bacterial pathogens of BRDC are identified 
by isolation of that pathogen from lungs that have gross or 
histologic lesions consistent with BRDC. However, tissues 
or clinical specimens from diagnostic submissions are fre-
quently from animals that have been treated with antimicro-
bials prior to submission and/or are chronic lesions. Many 
specimens have undergone autolysis and have bacterial over-
growth or environmental contamination from field postmor-
tem collection before receipt at a diagnostic laboratory. Some 
specimens have undergone temperature extremes during 
shipping that may impede the ability to isolate pathogens in 
culture. A 2014 study has demonstrated that gel-based PCR 
methodology was able to enhance the detection of bacterial 
pathogens in pneumonic lung tissues by ~20%, indicating 
that the potential for a large number of false-negative tests 
exists when relying on culture alone.1 Frequently, only the 
predominant organism is found given the overgrowth of a 
single agent; therefore PCR has been explored as a tool to 
identify potential coinfections in lung tissues.1
Real-time hydrolysis probe PCR (rtPCR) is a rapid tool 
that enables the relative abundance of these organisms to be 
calculated using quantification cycle (Cq) values, and thus 
provide additional data to assist the clinician in determining 
clinical relevance. Antemortem clinical samples, such as 
nasal swabs (NS) and deep nasopharyngeal swabs (DNPS) 
are frequently submitted to diagnostic laboratories for cul-
ture testing. The use of guarded swabs to sample deep naso-
pharyngeal passages has been shown to readily obtain M. 
bovis and M. haemolytica, although swab isolates may not 
always reflect those populations found in deeper tissues such 
as lung.3,8
We determined the utility of a multiplex rtPCR assay to 
detect bacterial pathogens of BRDC in clinical specimens 
(NS, DNPS, and lung tissue) commonly submitted to diag-
nostic laboratories for testing. We performed receiver operat-
ing characteristic (ROC) analyses to determine the 
quantification cycle (Cq) value as the optimal cutoff of a 
multiplex rtPCR assay by maximizing its test accuracy (both 
sensitivity [Se] and specificity [Sp] as the primary accuracy 
indices) compared to gold standards. Additionally, we com-
pared 2 rtPCR platforms, one that utilizes air heating and 
cooling on a rotary-based design with high-power light-emit-
ting diodes (RGQ; Rotor-Gene Q, Qiagen, Hilden, Germany) 
with a traditional block-based Peltier heating and cooling 
system (ABI; ABI 7500 Fast, Thermo Fisher Scientific, 
Waltham, MA) to determine if the type of rtPCR instrumen-
tation has an impact on results.
Materials and methods
Reference strains
Strains used for limit of detection analyses and preliminary 
validation of the assays included: P. multocida (ATCC BAA-
1113), M. haemolytica (ATCC BAA-410), H. somni (129Pt), 
and M. bovis (ATCC 25223; American Type Culture Collec-
tion, Manassas, VA). A collection of field isolates and off-tar-
get controls were also employed to ensure assay Sp (Table 1) 
and included Mannheimia granulomatis, Mannheimia vari-
gena, Mannheimia sp. Angen Group V, Bibersteinia trehalosi, 
Gallibacterium anatis, and Gallibacterium sp. All isolates, if 
not ATCC-sourced strains, were identified using matrix-
assisted laser desorption/ionization time-of-flight mass spec-
trometry (MALDI-TOF MS; Biotyper, Bruker Daltonics, 
Billerica, MA) to the species level with scores of 2.0 or higher 
and/or subjected to whole genome sequencing (Mannheimia 
sp. Angen Group V, Mannheimia varigena). The M. haemo-
lytica isolates represented all major genotypes and subtypes of 
M. haemolytica as described previously, and were identified to 
the species level using both MALDI-TOF MS and whole 
genome sequencing.4,15
Isolation and identification of bacteria from 
clinical specimens
Diagnostic specimens (NS, DNPS, and lung tissue) consisted 
of submissions to the University of Nebraska–Lincoln Vet-
erinary Diagnostic Center for bovine respiratory disease test-
ing. Samples included NS (n = 43), lung tissues (n = 47), 
and DNPS (n = 95). Although detailed clinical information 
was not available for many submissions, most of these sam-
ples were most likely collected from non-healthy clinically 
ill animals. Specimens were accessioned, processed, and 
tested by trained personnel following validated and approved 
standard operating procedures in an American Association of 
Veterinary Laboratory Diagnosticians (AAVLD)-accredited 
diagnostic laboratory. For bacterial culture, fresh lung tissues 
were trimmed, dipped in alcohol, the exterior was flame ster-
ilized, bisected, and the cut surface inoculated onto culture 
media. Swabs were directly inoculated onto plates if submit-
ted in a liquid medium, or suspended in a small volume of 
phosphate-buffered saline (PBS). Culture media, including 
tryptic soy agar with 5% sheep blood, chocolate agar, and 
MacConkey agar (Remel, Lenexa, KS), were inoculated and 
streaked for isolation. Samples were incubated in 5% CO
2
 
and examined at 24 and 48 h after inoculation. Colonies with 
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Table 1. Target and non-target isolates used to validate assay specificity for Mycoplasma bovis, Mannheimia haemolytica, Histophilus 
somni, and Pasteurella multocida. Template cell lysate was prepared using a 1 McFarland standard of pure culture growth. Quantification 
cycle (Cq) values for each target are reported using the Rotor-Gene Q instrument using threshold values of 0.1, except for red, which was 
set to 0.25, and green, which was set to 0.15. Dynamic tube normalization was used for all analyses.
Species/strain
Cq value
M. bovis M. haemolytica H. somni P. multocida
M. bovis
 UNL1 18.86 – – –
M. haemolytica
 USMARC 28284 – 20.02 – –
 USMARC 28454 – 19.1 – –
 USMARC 28229 – 20.06 – –
 USMARC 34142 – 19.30 – –
 USMARC 33749 – 19.14 – –
 USMARC 23580 – 19.19 – –
 USMARC 23533 – 18.73 – –
 USMARC 23570 – 19.16 – –
 USMARC 23217 – 18.53 – –
 USMARC 23473 – 23.22 – –
 USMARC 22604 – 16.81 – –
 USMARC 39434 – 17.26 – –
 USMARC 33204 – 19.2 – –
 USMARC 23299 – 23.06 – –
 USMARC 23311 – 20.61 – –
 USMARC 23348 – 20.56 – –
 USMARC 28226 – 25.99 – –
 USMARC 23309 – 19.73 – –
 USMARC 33982 – 23.54 – –
 USMARC 34180 – 18.40 – –
 USMARC 1590 – 17.92 – –
 USMARC 1621 – 20.08 – –
 USMARC 1562 – 22.24 – –
 USMARC 32563 – 24.86 – –
 USMARC 32635 – 21.14 – –
 USMARC 33170 – 22.44 – –
 USMARC 23456 – 19.63 – –
 USMARC 32864 – 20.69 – –
 USMARC 1629 – 20.55 – –
 USMARC 22549 – 20.23 – –
H. somni
 ATCC43625 – – 16.79  
 ATCC 700002 – – 17.97  
 UNL22 – – 13.41 –
 UNL21 – – 13.13 –
 UNL20 – – 22.86 –
 UNL19 – – 22.98 –
 UNL18 – – 26.61 –
 UNL17 – – 14.34 –
 UNL16 – – 21.75 –
P. multocida
 UNL15 – – – 10.07
 UNL14 – – – 13.73
 UNL13 – – – 13.37
 UNL12 – – – 12.65
(continued)
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morphology consistent with M. haemolytica, P. multocida, 
and/or H. somni were subjected to biochemical and/or other 
phenotypic or MALDI-TOF MS testing validated for defini-
tive identification of these organisms.
Nucleic acid extraction
For preliminary validations, nucleic acids were extracted 
from reference strains in pure subculture growth by picking 
several well-isolated colonies with a sterile stick and resus-
pending in 100 µL of nuclease-free water to a 1–2 McFar-
land standard turbidity. Cell suspensions were boiled at 
100°C for 10 min to lyse bacterial cells. Cell debris was 
clarified by centrifugation at 15,700 RCF for 2 min. Swab 
samples were resuspended in 200 µL of nuclease-free water 
and vortexed. One hundred µL of this eluent was transferred 
to a sterile 2-mL microcentrifuge tube. Lung tissue was 
placed in a filter Whirl-Pak (Nasco, Fort Atkinson, WI) with 
1–5 mL of sterile PBS and placed in a stomacher for 30–
60 s. Once stomached, as much fluid as possible was taken 
from the Whirl-Pak bag and placed in a 2-mL microcentri-
fuge tube. The tube was then spun at full speed (~13,500 × 
g) for 2 min. After centrifugation, 100 µL of the eluent was 
transferred to a sterile 2-mL microcentrifuge tube. These 
samples were then subjected to DNA extraction (QiaCube, 
DNeasy blood and tissue kit, Qiagen).
M. bovis gel-based PCR
The presence or absence of M. bovis was categorized using 
the previously validated PCR assay used currently in our 
laboratory (Lauerman L, et al. Nucleic acid amplification 
assays for diagnosis of animal diseases. Am Assoc Vet Lab 
Diagnosticians Workshop; 1998; Minneapolis MN). The 
assay included 25 µL of master mix, which contained 
16.9 µL of nuclease-free water, 2.5 µL of 10× PCR Rxn 
buffer, 2 µL of 50 mM MgCl
2
, 0.5 µL each of F primer 
(100 mM) and R primer (100 mM), 0.5 µL of dNTPs (100 
mM; Invitrogen, Carlsbad, CA), 0.1 µL of Taq DNA poly-
merase (Invitrogen), and 2 µL of template. The mix was then 
subjected to the following thermocycling conditions: 95°C 
for 3 min, followed by 45 cycles at 94°C for 40 s, 55°C for 
30 s, and 72°C for 1.5 min, ending at 72°C for 5 min. PCR 
products were analyzed using capillary gel electrophoresis 
(QIAxcel, Qiagen) and compared to a reference isolate used 
as a positive control.
Species/strain
Cq value
M. bovis M. haemolytica H. somni P. multocida
 UNL11 – – – 15.02
 UNL10 10.90
 UNL9 – – – 11.95
 UNL8 17.40
 UNL7 – – – 15.44
 UNL6 – – – 16.62
Mannheimia sp. Angen V
 USMARC 28377 – – – –
 USMARC 23448 – – – –
Mannheimia varigena
 USMARC 33577 – – – –
 USMARC 23064 – – – –
Mannheimia granulomatis
 ATCC 49244 – – – –
Actinobacillus pleuropneumoniae
 ATCC 27050 – – – –
Bibersteinia trehalosi
 ATCC 29703 – – – –
 UNL5 – – – –
 UNL4 – – – –
Gallibacterium anatis
 UNL3 – – – –
Gallibacterium sp.
 UNL2 – – – –
Dash (–) = no amplification detected (Cq of 0). Instrument source: Rotor-Gene Q, Qiagen, Hilden, Germany.
Table 1. (continued)
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Real-time PCR assay design
Primers and probes for the multiplex PCR assay were 
designed using a previously described assay for M. bovis.22 
Targets for M. haemolytica,6 P. multocida,14 and H. somni26 
were selected from previously described gene targets found 
to discriminate these organisms with additional reference 
sequences found in GenBank (Supplementary Table 1). Gene 
sequences from these targets were identified using BLASTn 
(https://blast.ncbi.nlm.nih.gov/), aligned, and utilized for 
primer design using PrimerQuest software with settings for a 
probe-based assay design (Integrated DNA Technologies 
[IDT], Iowa City, IA; Table 2). Primer sequences were evalu-
ated in silico with reference sequences where available. The 
sequences included 21 fully assembled genomes of P. multo-
cida, 4 of which were from cattle (Supplementary Fig. 1), 9 
fully assembled genomes of H. somni (Supplementary Fig. 
2), 14 fully assembled genomes of M. haemolytica (Supple-
mentary Fig. 3), and 9 fully assembled genomes of M. bovis 
(Supplementary Fig. 4). Additionally, the lktD locus of 1,133 
M. haemolytica isolates sequenced in a previous study was 
used for screening of potential polymorphisms at the primer-
binding sites.4
Primers and probe sequences were selected that were 
unique and did not possess significant identity to other 
sequences in GenBank, with the exception of M. haemolytica 
(Table 2). M. haemolytica had some sequence identity with 
closely related species; however, some polymorphisms were 
present in primer and probe-binding sites for non-target spe-
cies (Supplementary Fig. 5). All of the primers and probes 
were synthesized and purchased from IDT, except minor 
groove binder probes used for the internal control (Molecular 
Probes, Thermo Fisher Scientific). These primers and probes 
were combined with a heterologous internal control target 
system11 (intype IC DNA, Qiagen) and run on a rotary real-
time PCR instrument (hereafter RGQ; Rotor-Gene Q, Qia-
gen) in a single 5-plex reaction, or run on a block-based 
Peltier real-time thermocycling system in a 4-plex reaction 
without an internal control (hereafter ABI; ABI 7500 Fast, 
Thermo Fisher Scientific).
The number of detection channels, requirements for pas-
sive reference dyes, light source, and temperature kinetics of 
the 2 instruments varied; therefore, separate protocols were 
used. Protocols were independently optimized for primer and 
probe concentrations and annealing temperatures, and subse-
quently evaluated utilizing different instruments. For ABI, 
the 25-µL PCR master mix contained 6.1 μL of nuclease-
free H
2
O, 12.5 μL of 2× Quantifast multiplex PCR master 
mix (Qiagen), 0.4 μL of 50× ROX solution, 1 µL of each 
primer–probe mix (4 total µL) containing F (10 μM), R 
(10 μM), and P (10 μM), and 2.0 µL of template DNA. For 
Table 2. Oligonucleotide sequences for primers and probes used in the assay. For Histophilus somni probe, JOE-labeled probe was 
used in the ABI assay, and the Cy5.5-labeled probe was used for the RGQ assay.
Target/primer or probe Sequence (5’–3) Size Reference
Mycoplasma bovis (oppD)
 PMB996-F TCAAGGAACCCCACCAGAT 71 22
 PMB1066-R AGGCAAAGTCATTTCTAGGTGCAA  
 Mbovis1016 (FAM/TAMRA) TGGCAAACTTACCTATCGGTGACCCT  
Mannheimia haemolytica (LktD)
 F CTGCAACAAAGCCGATATCTTT 95 Current study
 R TACGACTGCTGAAACCTTGAT  
 P (CY5/BHQ) ACACATCGTCTTCCGGCACAATGA  
Histophilus somni (31kD)
 F GCAATGATGTACCWGCCAAAG 111 Current study
 R CCTTCAGCTCACCATTACCATA  
 P (JOE/BHQ) TTGCTTACGTCCAAACCGTCGTGT  
 P2 (Cy5.5/BHQ) TTGCTTACGTCCAAACCGTCGTGT  
Pasteurella multocida (Pm1231)
 F ATCCCTGCGTTACAGAGTTTAG 110 Current study
 R GACGYGGGYAGTACCATAAA  
 P (Texas Red/BHQ) TTGATGCCTTCTTTGCGGGTTTCG  
Internal control
 IC-1F GACCACTACCAGCAGAACAC 177 11
 IC-2R CTTGTACAGCTCGTCCATGC  
 PNED/MGBNFQ AGCACCCAGTCCGCCCTGAGCA  
M. bovis
 M. bovis-F TGATAGCAATATCATAGCGGC *
 M. bovis-R GTAGCATCATTTCCTATGCTAC 415  
ABI = ABI 7500 Fast, Thermo Fisher Scientific, Waltham, MA; RGQ = Rotor-Gene Q, Qiagen, Hilden, Germany.
*Lauerman L, et al. Nucleic acid amplification assays for diagnosis of animal diseases. Am Assoc Vet Lab Diagnosticians Workshop; 1998; Minneapolis MN.
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RGQ, the 25-µL PCR master mix contained 10 μL of 2× 
Quantifast multiplex PCR master mix (Qiagen), 1.0 μL of 
each primer–probe mix (5 μL total) containing F (10 μM), 
R (10 μM), and P (10 μM), and 5.0 µL of template DNA. 
The PCR reactions were subjected to thermocycling under 
the following conditions: 95°C for 5 min, then 45 cycles of 
95°C for 15 s, 60°C for 45 s. Cq was established by subtract-
ing 10% from the peak fluorescence intensity of the positive 
control for ABI. This was set manually by adjusting the base-
line up to the peak fluorescence of the positive control curve 
and then taking 10% of that value, resulting in a Cq of 0.01–
0.1. The Cq threshold for the RGQ was set at a fixed value of 
0.1 for all detection channels, except crimson, which was set 
at 0.05 in clinical samples. For undiluted DNA extracted 
from pure culture, thresholds were set at threshold values of 
0.1, except for red, which was set to 0.25, and green, which 
was set to 0.15. Dynamic tube normalization was used for all 
analyses on RGQ.
Preliminary assay validation and analytical Se
The multiplex PCR assays were initially validated using 
ATCC control organisms and reference bacterial isolates. 
Target and off-target validation controls were run in undi-
luted clarified cell lysate suspension in single reaction on the 
RGQ platform (Table 1). For analytical Se, ATCC reference 
isolates were used to generate standards and run on both 
instruments. Briefly, sterile brain–heart infusion (BHI) broth 
(P. multocida and M. haemolytica; Oxoid, Hants, UK), BHI 
supplemented with 0.5% yeast extract and 0.05% thiamine 
monophosphate (H. somni), and mycoplasma broth (M. 
bovis; Udder Health Systems, Meridian, ID) was inoculated 
with several isolated colonies of fresh growth and shaken at 
200 rpm for ~4 h at 37°C at a 1:10 flask-to-media ratio under 
atmospheric conditions (P. multocida and M. haemolytica) or 
incubated in 5% CO
2
 without shaking (H. somni and M. 
bovis). Cultures of M. bovis were incubated for ~24 h. Opti-
cal density from cultures was measured and adjusted to ~0.26 
absorbance (OD
600
) using a spectrophotometer (UV GENE-
SYS 140, Thermo Fisher Scientific). Cultures were serially 
diluted in 10-fold dilutions in sterile PBS and plated onto 
trypticase soy agar with 5% sheep blood (P. multocida and 
M. haemolytica), chocolate agar (H. somni; Remel), or 
mycoplasma agar (M. bovis; Udder Health Systems) incu-
bated at 37°C in 5% CO
2
. Colonies enumerated and colony-
forming units (CFU)/mL were calculated. Remaining 
dilutions were immediately placed on ice, and nucleic acid 
was extracted as described above.
Statistical analysis
Statistical analyses were conducted to 1) determine the opti-
mal thresholds for the detection of H. somni, M. haemolytica, 
and P. multocida, for RGQ and ABI rtPCR assays compared 
to culture or gel-based PCR (M. bovis) as gold standards, 
respectively, and 2) to evaluate the concordance between 
RGQ and ABI assays. Analyses were performed using either 
all data or data stratified by pathogens and sample matrices. 
All statistical analyses were performed in R v.3.2.3 (https://
www.r-project.org/).
Threshold determination
ROC curves were plotted to determine pathogen-detection 
thresholds, by using the pROC package in R.20 ROC curve is 
a plot of the true-positive rate (Se) against the false-positive 
rate (1 − Sp) for a series of possible cut-points of a test by 
comparison to the gold standards, which facilitated setting 
the optimal thresholds for the tests by balancing the tradeoff 
of test Se and Sp. For M. haemolytica, P. multocida, and H. 
somni, culture isolation and identification were used as the 
gold standard. For M. bovis, the gel-based PCR approach 
was used in lieu of culture as a gold standard, because this 
was the validated standard approach to M. bovis detection 
used in our laboratory.
The Cq value of “0” for RGQ and ABI rtPCR assays was 
replaced by “50” in the whole dataset, which was larger than 
the largest observed Cq value in the dataset. A rtPCR result 
of “0” indicated the absence of DNA products, which should 
be referred to as a negative result. However, the calculations 
in the roc() function assumed a Cq value equal to or smaller 
than a cut-point referred to a positive result. With this 
assumption, a PCR result of “0” would be referred to as a 
positive detection. Changing zeros to a value greater than the 
largest Cq value in the whole dataset guaranteed a consistent 
analysis that accurately reflected the PCR results.
Specificity and Se values of the optimal thresholds were 
computed and presented as percentages. The 95% confidence 
intervals (CI) of the Se and Sp values were computed with 
2,000 stratified bootstrap replicates using the ci.thresholds() 
function in the {pROC} package. ROC curves were plotted 
with the indication of the Se (%) and Sp (%) of computed 
optimal thresholds.
Concordance analysis
Performance of RGQ and ABI rtPCR assays were evaluated 
by comparing the difference in the mean Cq values of both 
assays by ANOVA and Cohen kappa statistic.5 A p ⩽ 0.05 
was considered statistically significant.
Linear regression models were developed using the 
“lm()” function to compare RGQ and ABI real-time Cq val-
ues using ANOVA. The equations included “organism” and/
or “source” variables as potential modifiers on the associa-
tion between Cq values obtained by RGQ and ABI assays, 
which were all categorical data with more than 2 mutually 
exclusive categories. For example, the factor “organism”, 
contained 4 categories of “H. somni”, “M. haemolytica”, 
“M. bovis”, and “P. multocida”. A dummy coding approach 
was used to develop the linear regression models to estimate 
the impact of effect modifiers on the association of interest. 
To dummy code the k categories, where k denotes the num-
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ber of levels of a specific factor (for example regarding the 
“organism”, k = 4), k – 1 dummy variables needed to be 
constructed (D
i
, i = 1, …, k – 1, where D
i
 denoted dummy 
variables for a specific factor), with D
i
 set to 1 if a case was 
in category i, otherwise to 0.10 Regarding the factor “organ-
ism” for example, dummy variables of “M. haemolytica”, 
“M. bovis”, and “P. multocida” were constructed, which 
means “H. somni” was set as the reference category. Hence, 
pathogen dummy variables (“M. haemolytica”, “M. bovis”, 
and “P. multocida”) are all set to “0” for cases in the cate-
gory of “H. somni”. In the case of M. haemolytica–associ-
ated test results, the pathogen dummy variable setting was 
“M. haemolytica” = 1, “M. bovis” = 0 and “P. multocida” 
= 0. The same approach was applied to variable “source”. 
The comparison was done by “Anova” function in the 
“{car}” package. For example, ABI results were the 
response values in the linear regression model for the data-
set containing all of the information for the sample source 
“lung tissue”, where RGQ results and organism type were 
the explanatory variables. ANOVA calculated a p value 
determining the significance of the coefficient for the RGQ 
test results, where p ⩽ 0.05 indicated a significant associa-
tion between the Cq values of RGQ and ABI. For ANOVA, 
Cq values of “0” were kept as they were, and the equations 
showing the significant relationship between ABI and RGQ 
values for each dataset were included in the results.
Cohen kappa statistic was used to explore the concor-
dance between RGQ and ABI results, as well as the com-
parisons of RGQ and ABI (at their optimal thresholds) with 
the gold standard results, respectively. Cq values of “50” 
were used to replace “0” for the same aforementioned rea-
son. The following categories were assigned for the agree-
ment associated with kappa statistic: <0 indicating no 
agreement, 0–0.20 slight, 0.21–0.40 fair, 0.41–0.60 moder-
ate, 0.61–0.80 substantial, and 0.81–1 almost perfect agree-
ment.13 The “kappa2” function in the {“irr”} package was 
used for the calculations.10
Results
Analysis performed in silico demonstrated that all primer 
sequences used for the assay had 100% identity to all refer-
ence sequences isolated from the target species (bovine). 
Preliminary validation of test Sp demonstrated no amplifica-
tion of non-target species (Cq of 0) for each non-target refer-
ence culture isolate tested (Table 1). However, in silico 
analysis indicated that closely related species, such as 
Mannheimia glucosida and Mannheimia ruminalis, have 
high sequence identity with target sequences, where in some 
cases only a single polymorphism was present in the primer–
probe sequences (Supplementary Fig. 5).
The assay limits of detection were calculated using refer-
ence bacterial isolates (Table 3). The assays were character-
ized as having limits of detection and corresponding Cq 
values for M. haemolytica as 24 CFU/reaction (ABI Cq 33.9) 
or 2.4 CFU/reaction (RGQ Cq 37.6); for P. multocida 12 
CFU/reaction (ABI Cq 36.3) or 1.2 CFU/reaction (RGQ Cq 
31.7); for H. somni 12 CFU/reaction (ABI Cq 34.7) or 1.2 
Table 3. Sensitivity and limit of detection in colony-forming units per reaction (CFU/rxn) for both assays using characterized 
reference strains of each isolate. Limit of detection utilized reference strains Pasteurella multocida (ATCC BAA-1113), Mannheimia 
haemolytica (ATCC BAA-410), Histophilus somni (129Pt), and Mycoplasma bovis (ATCC 25223).
Organism CFU/rxn
Cq RBQ ABI
ABI RGQ R2 RE R2 RE
M. haemolytica 2,400 28.2 27.4  
 240 31.69 31.38  
 24 33.96 34.43  
 2.4 – 37.67 0.998 1.01 0.998 0.996
P. multocida 1,200 30.46 26.08  
 120 34.21 29.05  
 12 36.38 31.72  
 1.2 – – 0.999 1.00 0.993 0.97
H. somni 1,200 30.60 28.02  
 120 33.06 30.49  
 12 36.26 35.05  
 1.2 – 37.6 0.999 1.02 0.993 1.06
M. bovis 1,200 30.12 25.98  
 120 33.67 29.97  
 12 37.4 33.31  
 1.2 – 36.34 0.998 0.95 0.997 0.91
ABI = ABI 7500 Fast, Thermo Fisher Scientific; Cq = quantification cycle; dash (–) = no amplification detected; RE = reaction efficiency (10^(–1/m) – 1); RGQ = Rotor-Gene 
Q, Qiagen.
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CFU/reaction (RGQ Cq 37.6); and for M. bovis 12 CFU/
reaction (ABI Cq 37.4) or 1.2 CFU/reaction (RGQ Cq 36.3).
The most prevalent finding in diagnostic specimens using 
the culture or gel-based PCR approach was P. multocida (n 
= 88), followed by M. haemolytica (n = 63), M. bovis (n = 
23), and H. somni (n = 14; Table 4). When classified accord-
ing to rtPCR results only, levels of detection increased, with 
M. haemolytica the most prevalent (n = 136), followed by P. 
multocida (n = 119), M. bovis (n = 54), and H. somni (n = 
48; Table 4). Co-detections were frequently found (Table 4), 
with the most frequent combination being M. haemolytica 
and P. multocida (n = 98). Thus, compared to rtPCR, gold 
standard testing detected 29%, 43%, 46%, and 74% of H. 
somni, M. bovis, M. haemolytica, and P. multocida positive 
samples, respectively.
When examining co-detections based on sample type, the 
number of lung tissues that were positive for 2 or more 
pathogens using the least stringent criterion (RGQ platform 
with a Cq value of ⩽ 40) was 26. This was an additional 8 
co-detections over the 18 using culture and gel-based PCR. 
For antemortem samples, there were 125 specimens with 2 
or more pathogens detected, which was much more than the 
25 co-detections that were found with culture and gel-based 
PCR. Much of this enhanced detection may have been the 
result of detection of non-viable organisms that could not be 
isolated using the culture approach. However, one exception 
was H. somni, in which case 4 lung samples were positive by 
culture, but negative by rtPCR on both platforms (Supple-
mentary Table 3). These isolates were subsequently re-grown 
in pure culture; the lysates were tested using both PCR plat-
forms, and were positive with comparable Cq values to other 
H. somni run in pure culture.
Other discrepant results with negative rtPCR and positive 
culture results were one M. haemolytica isolate from a NS 
and a DNPS, a P. multocida isolated from a lung, and 3 from 
DNPS that were cultured but not detected by either PCR 
assay (Supplementary Table 3). These isolates were lost to 
follow-up, so they could not be further evaluated by testing 
isolates. However, discrepant results may be the result of 
misclassification of the organism from the initial isolate 
identification, primer–probe mismatch with the isolate, or 
extraction errors.
Cq cutoff values were calculated to maximize agreement 
between culture results (gold standard test) and rtPCR results 
using ROC analysis. Values ranged from a minimum of 29.8 
for M. haemolytica in lung matrices using the RGQ assay to 
a maximum of 44.9 for P. multocida in NS matrices run on 
the ABI (Supplementary Table 2). Pathogen-specific cutoff 
Cq values across matrices ranged from a low of 33.4 for M. 
haemolytica on the ABI to 44.9 for P. multocida on the ABI 
(Supplementary Table 2). Overall Cq values for all assays 
were significantly lower (p ⩽ 0.05) on the RGQ (35.2) than 
the ABI (39.7), indicating a significantly lower detection 
limit threshold of the RGQ, in general. As the ROC-based Cq 
values were calculated by maximizing agreement of rtPCR 
tests and the gold standard culture tests, the values are not 
indicative of the analytical cutoffs of CFU numbers beyond 
which quantitative results from rtPCR are valid. Instead, the 
Cq values refer to cutoffs that would need to be applied to 
enable the rtPCR methods to produce a result similar to the 
gold standard from both Se and Sp perspectives, and were 
calculated for comparative purposes.
ROC analysis of the 4 pathogens across all 3 sample types 
demonstrated very similar levels of Se and Sp between the 2 
instruments compared to the gold standard (Fig. 1; repre-
sented by overall equations of ABI = 0.27 + 0.46 × RGQ + 
2.49 × M. bovis + 5.37 × M. haemolytica + 7.17 × P. mul-
tocida – 3.33 × lung − 0.83 × nasal), where ABI and RGQ 
represented the Cq values measured by these 2 types of 
instruments; M. bovis, M. haemolytica, and P. multocida 
were the dummy variables for pathogen types; and lung and 
nasal were the dummy variables for sample matrices. This 
equation could be used to quantify the association between 
Cq values measured by ABI and RGQ. For example, to 
examine the association between M. haemolytica in lung tis-
sues, the pathogen dummy variables were set as “M. haemo-
lytica” = 1, “P. multocida” = 0, and “M. bovis” = 0, and 
matrices dummy variables were set as “Lung” = 1 and 
“Nasal” = 0. This resulted in ABI = 2.31 + 0.46 × RGQ.
The agreement between instruments on each assay was 
also very high, with substantial to almost perfect agreement 
for all pathogens and matrices by kappa statistic for inter-
instrument agreement (⩾0.784), except for H. somni (Sup-
plementary Table 2). For H. somni in lung and DNPS 
Table 4. Frequency of coinfections across all sample types. PCR results were categorized as positive if pathogen was detected in ⩽40 
quantification cycles on either instrument.
M. haemolytica P. multocida H. somni M. bovis
 PCR Culture PCR Culture PCR Culture PCR Conv PCR
Mannheimia haemolytica (136) (63) 98 27 38 1 27 7
Pasteurella multocida x x (119) (88) 36 6 24 7
Histophilus somni x x x x (48) (14) 20 6
Mycoplasma bovis x x x x x x (54) (23)
Conv PCR = conventional PCR; x = 185 total samples. Numbers in parentheses are the total number of positives detected.
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matrices, agreement was only moderate (0.619 and 0.54, 
respectively). Additionally, for all pathogens except H. 
somni, agreement with lung tissue gold standard testing was 
highest, and had substantial or nearly perfect agreement with 
gold standard testing. DNPS also provided mostly moderate 
levels of agreement (0.525–0.664) with gold standard testing 
for pathogens, except for H. somni, which had substantial 
levels of agreement with gold standard testing for both assays 
(0.694 and 0.789). Nasal swab matrices had the lowest over-
all agreement with gold standard testing, with fair-to-moder-
ate levels of agreement (0.353–0.525).
Discussion
In our study, the culture-based result for M. haemolytica, H. 
somni, and P. multocida, or gel-based PCR result for M. 
bovis, was considered the gold standard, and both gave a 
dichotomous outcome of positive or negative for the target 
pathogen. The rtPCR assay produced a continuous outcome 
(i.e., the Cq value), which allowed flexibility to design the 
assay for multiple purposes by varying the Cq cutoff to trans-
fer the continuous outcome into an answer of positive or 
negative. For example, the optimal cutoff value of Cq of the 
multiplex rtPCR approach in our study was determined by 
trading off Se and Sp using ROC to maximize the similarity 
of results produced by the multiplex rtPCR assay and the 
gold standard. Because the rtPCR is much more sensitive 
than the gold standard for detecting these bacterial species, 
the Se and Sp for rtPCR look low. Therefore, it may not 
always be reasonable to compare the superiority of a PCR 
assay over the gold standard based on the Se and Sp values 
determined by our approach.
If the purpose was to design a “rule-out” test with a high 
Se to detect a pathogen, a higher Cq cutoff could be used. 
When a cutoff of 40 was used for M. haemolytica in DNPS, 
the multiplex rtPCR assay had fewer false-negatives com-
pared to the gold standard. As a result, a very high Se of 
97.4% was found for the new test (vs 74% based on the opti-
mal cutoff), which indicates that a true infection can be 
detected at a probability of 97.4%, although it is compro-
mised by a lower Sp of 41% (vs 78% based on the optimal 
cutoff). This is the ideal property of a test to rule out the 
presence of the infection by a particular pathogen when a 
negative result is observed. Conversely, lower cutoffs would 
be more likely to identify infections with a particular patho-
gen of interest; in other words, higher Sp giving a better 
“rule-in” test with a compromise of lower Se. Given that 
BRDC is comprised of multiple opportunistic pathogens that 
may exist in normal animals at various levels, especially in 
antemortem clinical samples, interpretation of testing results 
is complex, and therefore multiple strategies were used to 
assess the rtPCR test and to compare results to traditional 
detection techniques. The Cq cutoff applied should reflect 
the goals of the test, and could be applied to either a “rule-in” 
or a “rule-out” diagnostic approach. Further clinical trials 
could also be conducted to relate shedding of BRD patho-
gens in antemortem samples to find Cq cutoffs that maxi-
mize agreement with clinical signs and/or the presence of 
postmortem lesions.
In general, lung tissues had higher agreement than other 
samples with the culture or gel-based PCR, followed by 
DNPS and NS. However, some discrepancies, such as those 
found with H. somni, were attributed to sampling differences 
between the tissue utilized for culture versus extracted for 
PCR. H. somni infections may be more prone to this type of 
sampling error, because the lung lesions can be more vari-
able in distribution and type. Bovine respiratory disease 
caused by H. somni is typically a bilateral lobar pneumonia 
in the cranioventral lung; however, chronic infections may 
induce necrotic foci that are distributed unevenly. Addition-
ally, given that H. somni can cause septicemia, pneumonia 
may also be interstitial, which may have significantly differ-
ent pathogen distribution within tissues.17
Less agreement in DNPS and NS was likely the result of 
contaminating environmental organisms that are typically 
present in the upper respiratory tract, which can rapidly out-
grow pathogens on culture plates and lead to false-negative 
Figure 1. Receiver operating characteristic curves depicting 
the concordance between the ABI and RGQ real-time PCR (rtPCR) 
assays based on a crude comparison regardless of pathogens and 
sample types. The rtPCR assays evaluated were the block-based 
Peltier real-time thermocycling system (ABI 7500 Fast, Thermo 
Fisher Scientific) and the rotary real-time PCR instrument (Rotor-
Gene Q, Qiagen). The gray diagonal line represents agreement 
between assays no better than chance alone. The gray solid and 
black dashed lines are the observed ROC curves for RGQ and 
ABI assays, respectively. The gray circle and black solid circle 
(arrow) have the greatest perpendicular distances from the diagonal 
line, suggesting the optimal quantification cycle values with the 
sensitivities and specificities of the RGQ and ABI rtPCR assays for 
pathogen detection.
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culture results. Survival and subsequent recovery of these 
organisms in swabs and in transport media can also be lower 
when compared to tissues, leading to false-negative culture 
results. Additionally, some of the pathogens, such as P. multo-
cida, can grow rapidly and be very mucoid, making culture 
assessment of mixed pathogen cultures challenging. There-
fore, although the agreement was lowest in swab samples, the 
PCR methodology may be most useful for these given the 
potential for high false-negative culture rates in these speci-
men types. However, even though detection is enhanced 
using a PCR-based approach, phenotypic testing of suscepti-
bility would not be possible without an isolate, therefore cul-
ture is still required to guide antimicrobial therapy, and as 
stated above, mere detection of these pathogens may not indi-
cate clinical infection.
The RGQ yielded significantly lower Cq cutoffs that maxi-
mized agreement with gold standards over the ABI instrument, 
in agreement with previous work.19 This is potentially because 
the more precise temperature control and rapid temperature 
adjustment enhanced overall PCR efficiency. Some differences 
may be the result of how the Cq threshold values were applied; 
however, the threshold levels used for the ABI were uniformly 
lower, and thus would likely have lowered overall Cq com-
pared to the RGQ. However, these differences in corresponding 
Cq values did not affect the overall Se and Sp of the assays, 
whereby the ABI and RGQ were nearly identical when the Cq 
cutoff values that maximized these values were applied.
Detection of pathogens in samples with rtPCR, especially 
in the absence of postmortem lesions, may not indicate the 
presence of disease. For antemortem samples, further 
research is needed to determine if a specific Cq cutoff used 
to assess nasal shedding levels can be used to maximally pre-
dict a clinical infection, given that many of these agents colo-
nize the upper respiratory tract in normal, clinically healthy 
animals; stressed and sick cattle may have higher levels of 
shedding, and thus lower Cq values. Currently, pathogen 
burdens and shedding can be estimated based on the Cq 
value and copy number, but how to best apply this informa-
tion to clinical treatment is an area for further study, because 
relevant clinical data that may allow for classification of 
these specimens is unavailable. However, the samples tested 
were from submissions from presumably non-healthy cattle, 
and therefore may not be representative of normal healthy 
animal populations. A multiplex hydrolysis probe rtPCR 
assay when utilized in either an RGQ or ABI instrument 
heavily increases the number of bovine respiratory patho-
gens that can be detected in NS, DNPS, and lung tissues over 
culture and gel-based PCR assays. The utilization of high-
throughput extraction methods in conjunction with this assay 
would provide results in a matter of hours, rather than days, 
over culture methodology. This would strongly enhance the 
ability to detect pathogens in highly mixed specimens such 
as NS and DNPS, enabling veterinarians and clinicians to 
diagnose disease and administer treatment or implement pre-
vention strategies more rapidly.
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